Home
- Naturade Significantly Strengthens Balance Sheet; Receives $2.5 Million in Capital from Westgate Equity Partners, L.P.
- Natrol Appoints Vincent Andrich VP Sales for Prolab Division
- Vermont Pure Holdings, Ltd. Announces Record Fiscal Year 2001 Results
- Body Shop Reports 24.8 Mil Euro Sales Revenues
- Spectrum Organic Products Responds to FDA Letter Regarding Use of Non-GMO Seal on Canola Oil Label
- Supplement Group Targets Consumer Education
- Advanced Nutraceuticals, Inc. Announces 2001 Year End Results And Additional Financing
- ADM Awarded Nutraceuticals Patent Patent Creates Proprietary Position for ADM in Fast-Growing Nutraceutical Market
- Tantivy Sciences Obtains Exclusive License to Unique Nutraceutical Products
- Top GNC Executives Tour Pittsburgh Market to Present New Business Plan and Expansion Possibilities; Meeting will focus on new business strategies and growth
- Nutrition 21 Receives Patent For the Nutritional Treatment of Type 2 Diabetes; Patent Presents New Pharmaceutical Licensing Opportunities
- ConsumerLab.com Finds Most B-vitamin Supplements Contain What They Claim, But Often Exceed Safe Levels - Consumers Cautioned to Be Aware of Side Effects with High Dose Products
- Nutraceutix, Inc., Nutravite Announcement Commercial Availability of CDT™ Glucosamine for Canadian Marketplace
- Harvey Kamil Appointed President of NBTY, Inc. - Scott Rudolph to Continue as Chairman and CEO
- drugstore.com Expects to Reach Profitability Target in 2003
- Human Genome Project Leads to Innovative Healthcare
- NPIcenter’s Career Center targets nutraceutical Industry
- Adding Vitamin C To Certain Drugs May Help Treat Alzheimer's, Other Brain Disorders
- Adding Vitamin C To Certain Drugs May Help Treat Alzheimer's, Other Brain Disorders
- Editorial: An Exercise in Synergy
- NBTY, Inc. Appoints Harvey Kamil President, Scott Rudolph To Continue As Chairman And CEO
- Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids
- Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids
- Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids
- LignisulMSM vs Naproxen for Osteoarthritis Clinical Trial Gets Underway
- Natural Health Trends Corp. Launches Lexxus Taiwan
- FDA Presents Compliance Guide for Structure/Function Claims
- New TrimFit® Bars Redefine Energy Bar Category
- New TrimFit® Bars Redefine Energy Bar Category
- Probiata® Offers Safe, Natural and Effective Alternative
- Alive & Well with Michelle Harris
- Be Well and Get Rewarded! Find Personalized Wellness Solutions and Earn Free Vitamins at NatureMade.com
- Consumers Search for Healthy Cleaning Products That Work
- Nordic Naturals: Omega 3 Fatty Acids
- Cyanotech Names Bob Capelli as Director of Sales
- Study Demonstrates Cardioprotective Effects of Protykin(R)
Study results presented at Federation of American Societies for Experimental Biology (FASEB) Experimental Biology 2005 conference, supports research indicating that supplementation with Protykin provides cardio protection through a mechanism known as ischemic preconditioning.
- Study Demonstrates Cardioprotective Effects of Protykin(R)
Study results presented at Federation of American Societies for Experimental Biology (FASEB) Experimental Biology 2005 conference, supports research indicating that supplementation with Protykin provides cardio protection through a mechanism known as ischemic preconditioning.
- OatVantage Proves Superiority In Building Cholesterol-Lowering Viscosity
Product increases intestinal viscosity greater than any similarly tested commercial oat product.
- OatVantage Proves Superiority In Building Cholesterol-Lowering Viscosity
Product increases intestinal viscosity greater than any similarly tested commercial oat product.
- OatVantage Proves Superiority In Building Cholesterol-Lowering Viscosity
Product increases intestinal viscosity greater than any similarly tested commercial oat product.
- Martek Releases Preliminary Results of Cardiovascular Study
Study found that after 13 weeks, the group taking 1g of DHA per day had significantly lower triglyceride levels than the placebo group, and at 26 weeks, the same group had significantly lower triglyceride levels compared to baseline, but the reduction was not statistically significant compared to the placebo group, (which was the study's primary endpoint).
- Martek Releases Preliminary Results of Cardiovascular Study
Study found that after 13 weeks, the group taking 1g of DHA per day had significantly lower triglyceride levels than the placebo group, and at 26 weeks, the same group had significantly lower triglyceride levels compared to baseline, but the reduction was not statistically significant compared to the placebo group, (which was the study's primary endpoint).
- Martek Releases Preliminary Results of Cardiovascular Study
Study found that after 13 weeks, the group taking 1g of DHA per day had significantly lower triglyceride levels than the placebo group, and at 26 weeks, the same group had significantly lower triglyceride levels compared to baseline, but the reduction was not statistically significant compared to the placebo group, (which was the study's primary endpoint).
- Martek Releases Preliminary Results of Cardiovascular Study
Study found that after 13 weeks, the group taking 1g of DHA per day had significantly lower triglyceride levels than the placebo group, and at 26 weeks, the same group had significantly lower triglyceride levels compared to baseline, but the reduction was not statistically significant compared to the placebo group, (which was the study's primary endpoint).
- Martek Releases Preliminary Results of Cardiovascular Study
Study found that after 13 weeks, the group taking 1g of DHA per day had significantly lower triglyceride levels than the placebo group, and at 26 weeks, the same group had significantly lower triglyceride levels compared to baseline, but the reduction was not statistically significant compared to the placebo group, (which was the study's primary endpoint).
- Largest Trial of Vitamin E Shows Heart Health Benefit For Women
results of a new study involving nearly 40,000 healthy women finds that vitamin E significantly reduced the risk of death from cardiovascular disease; study, published in the July 6 edition of the Journal of the American Medical Association, also confirmed that vitamin E is safe.
- Largest Trial of Vitamin E Shows Heart Health Benefit For Women
results of a new study involving nearly 40,000 healthy women finds that vitamin E significantly reduced the risk of death from cardiovascular disease; study, published in the July 6 edition of the Journal of the American Medical Association, also confirmed that vitamin E is safe.
- Largest Trial of Vitamin E Shows Heart Health Benefit For Women
results of a new study involving nearly 40,000 healthy women finds that vitamin E significantly reduced the risk of death from cardiovascular disease; study, published in the July 6 edition of the Journal of the American Medical Association, also confirmed that vitamin E is safe.
- Largest Trial of Vitamin E Shows Heart Health Benefit For Women
results of a new study involving nearly 40,000 healthy women finds that vitamin E significantly reduced the risk of death from cardiovascular disease; study, published in the July 6 edition of the Journal of the American Medical Association, also confirmed that vitamin E is safe.
- Largest Trial of Vitamin E Shows Heart Health Benefit For Women
results of a new study involving nearly 40,000 healthy women finds that vitamin E significantly reduced the risk of death from cardiovascular disease; study, published in the July 6 edition of the Journal of the American Medical Association, also confirmed that vitamin E is safe.
- Largest Trial of Vitamin E Shows Heart Health Benefit For Women
results of a new study involving nearly 40,000 healthy women finds that vitamin E significantly reduced the risk of death from cardiovascular disease; study, published in the July 6 edition of the Journal of the American Medical Association, also confirmed that vitamin E is safe.
- Study Shows Vitamin E has Heart Health Benefit for Women
A long term Vitamin E study on healthy women, reported in the July 6 issue of the Journal of the American Medical Association, (JAMA) indicates that not only is Vitamin E safe, it significantly reduced the risk of death from major cardiovascular events (heart attack, stroke) by 24% and those over 65 years old experienced an even greater benefit.
- Study Indicates That Tocotrienol Is More Effective Than a-Tocopherol In Reducing Expression of Adhesion Molecules
Study indicates that tocotrienols were a more effective form of vitamin E in reducing endothelial expression of adhesion molecules in the blood vasculature, relative to the effects of α-tocopherol.
- Study Indicates That Tocotrienol Is More Effective Than a-Tocopherol In Reducing Expression of Adhesion Molecules
Study indicates that tocotrienols were a more effective form of vitamin E in reducing endothelial expression of adhesion molecules in the blood vasculature, relative to the effects of α-tocopherol.
- Study Indicates That Tocotrienol Is More Effective Than a-Tocopherol In Reducing Expression of Adhesion Molecules
Study indicates that tocotrienols were a more effective form of vitamin E in reducing endothelial expression of adhesion molecules in the blood vasculature, relative to the effects of α-tocopherol.
- Study Indicates That Tocotrienol Is More Effective Than a-Tocopherol In Reducing Expression of Adhesion Molecules
Study indicates that tocotrienols were a more effective form of vitamin E in reducing endothelial expression of adhesion molecules in the blood vasculature, relative to the effects of α-tocopherol.
- Study Indicates That Tocotrienol Is More Effective Than a-Tocopherol In Reducing Expression of Adhesion Molecules
Study indicates that tocotrienols were a more effective form of vitamin E in reducing endothelial expression of adhesion molecules in the blood vasculature, relative to the effects of α-tocopherol.
- Yale Study Reaffirms Link Between Dark Chocolate and Cardiovascular Benefits
The study used ultrasound technology and sophisticated measurements to assess the effects of eating high-cacao content dark chocolate, Hershey's(R) Extra Dark, on the arterial function of 45 moderately overweight adults, and measured subjects' blood pressure before and two hours after eating two servings (74 grams) of dark chocolate, demonstrating improvements in blood pressure, as well as the ability of blood vessels to dilate and increase flow.
- Zila Cites Second Study Linking Ester-E(R) To Healthy Cardiovascular Function
In this animal study, Ester-E(R) significantly reduced LDL-C (so-called bad cholesterol), triglycerides, and plaque formation, while regular vitamin E had no significant effect.
- Zila Cites Second Study Linking Ester-E(R) To Healthy Cardiovascular Function
In this animal study, Ester-E(R) significantly reduced LDL-C (so-called bad cholesterol), triglycerides, and plaque formation, while regular vitamin E had no significant effect.
- Zila Cites Second Study Linking Ester-E(R) To Healthy Cardiovascular Function
In this animal study, Ester-E(R) significantly reduced LDL-C (so-called bad cholesterol), triglycerides, and plaque formation, while regular vitamin E had no significant effect.
- Zila Cites Second Study Linking Ester-E(R) To Healthy Cardiovascular Function
In this animal study, Ester-E(R) significantly reduced LDL-C (so-called bad cholesterol), triglycerides, and plaque formation, while regular vitamin E had no significant effect.
- Zila Cites Second Study Linking Ester-E(R) To Healthy Cardiovascular Function
In this animal study, Ester-E(R) significantly reduced LDL-C (so-called bad cholesterol), triglycerides, and plaque formation, while regular vitamin E had no significant effect.
- Effects of Red Wine Consumption on Risk Factors for Coronary Heart Disease
- Study: Chromium Picolinate May Provide Cardiovascular Benefits in Pre-Diabetes
Preclinical study on rats, conducted at the University of Alberta, and presented at the 3rd World Congress on Insulin Resistance Syndrome, shows daily use of chromium picolinate provides significant cardiovascular benefits in pre-diabetic rats that have insulin resistance
- Study: Chromium Picolinate May Provide Cardiovascular Benefits in Pre-Diabetes
Preclinical study on rats, conducted at the University of Alberta, and presented at the 3rd World Congress on Insulin Resistance Syndrome, shows daily use of chromium picolinate provides significant cardiovascular benefits in pre-diabetic rats that have insulin resistance
- Study: Chromium Picolinate May Provide Cardiovascular Benefits in Pre-Diabetes
Preclinical study on rats, conducted at the University of Alberta, and presented at the 3rd World Congress on Insulin Resistance Syndrome, shows daily use of chromium picolinate provides significant cardiovascular benefits in pre-diabetic rats that have insulin resistance
- Study: Chromium Picolinate May Provide Cardiovascular Benefits in Pre-Diabetes
Preclinical study on rats, conducted at the University of Alberta, and presented at the 3rd World Congress on Insulin Resistance Syndrome, shows daily use of chromium picolinate provides significant cardiovascular benefits in pre-diabetic rats that have insulin resistance
- Study: Chromium Picolinate May Provide Cardiovascular Benefits in Pre-Diabetes
Preclinical study on rats, conducted at the University of Alberta, and presented at the 3rd World Congress on Insulin Resistance Syndrome, shows daily use of chromium picolinate provides significant cardiovascular benefits in pre-diabetic rats that have insulin resistance
- Study: Chromium Picolinate May Provide Cardiovascular Benefits in Pre-Diabetes
Preclinical study on rats, conducted at the University of Alberta, and presented at the 3rd World Congress on Insulin Resistance Syndrome, shows daily use of chromium picolinate provides significant cardiovascular benefits in pre-diabetic rats that have insulin resistance
- New Cocoa Flavanol Study Provides Important Evidence on Why Plant Foods are Beneficial to Cardiovascular Health
Research published in the Proceedings of the National Academy of Sciences of the United States of America identifies the flavanol, (-)epicatechin, as one of the bioactive nutrients in cocoa that can improve the ability of blood vessels to relax.
- New Cocoa Flavanol Study Provides Important Evidence on Why Plant Foods are Beneficial to Cardiovascular Health
Research published in the Proceedings of the National Academy of Sciences of the United States of America identifies the flavanol, (-)epicatechin, as one of the bioactive nutrients in cocoa that can improve the ability of blood vessels to relax.
- New Cocoa Flavanol Study Provides Important Evidence on Why Plant Foods are Beneficial to Cardiovascular Health
Research published in the Proceedings of the National Academy of Sciences of the United States of America identifies the flavanol, (-)epicatechin, as one of the bioactive nutrients in cocoa that can improve the ability of blood vessels to relax.
- New Cocoa Flavanol Study Provides Important Evidence on Why Plant Foods are Beneficial to Cardiovascular Health
Research published in the Proceedings of the National Academy of Sciences of the United States of America identifies the flavanol, (-)epicatechin, as one of the bioactive nutrients in cocoa that can improve the ability of blood vessels to relax.
- New Cocoa Flavanol Study Provides Important Evidence on Why Plant Foods are Beneficial to Cardiovascular Health
Research published in the Proceedings of the National Academy of Sciences of the United States of America identifies the flavanol, (-)epicatechin, as one of the bioactive nutrients in cocoa that can improve the ability of blood vessels to relax.
- Study Indicates B Vitamins not Cardioprotective
- Study Indicates B Vitamins not Cardioprotective
- Study Indicates B Vitamins not Cardioprotective
- Study Indicates B Vitamins not Cardioprotective
- Study Indicates B Vitamins not Cardioprotective
- Study: Fish Oils Plus Statins Help Protect Heart
- Study: Fish Oils Plus Statins Help Protect Heart
- Study: Fish Oils Plus Statins Help Protect Heart
- Study: Fish Oils Plus Statins Help Protect Heart
- Study: Fish Oils Plus Statins Help Protect Heart
- Fish Oil Supplements Prevent Declines in Heart Rate Variability
- Fish Oil Supplements Prevent Declines in Heart Rate Variability
- Fish Oil Supplements Prevent Declines in Heart Rate Variability
- Fish Oil Supplements Prevent Declines in Heart Rate Variability
- Fish Oil Supplements Prevent Declines in Heart Rate Variability
- Study: Effect of Soy Diet on Mice with Hypertrophic Cardiomyopathy
- Study: Effect of Soy Diet on Mice with Hypertrophic Cardiomyopathy
- Study: Effect of Soy Diet on Mice with Hypertrophic Cardiomyopathy
- Study: Effect of Soy Diet on Mice with Hypertrophic Cardiomyopathy
- Study: Effect of Soy Diet on Mice with Hypertrophic Cardiomyopathy
- Tomato Extract May Help Lower Blood Pressure
- Tomato Extract May Help Lower Blood Pressure
- Tomato Extract May Help Lower Blood Pressure
- Tomato Extract May Help Lower Blood Pressure
- Tomato Extract May Help Lower Blood Pressure
- Study Indicates That Lyc-O-Mato® Reduces Blood Pressure
Randomized double blind, placebo controlled crossover trial, conducted at Ben-Gurion University, Israel, indicated that a daily intake of tomato extract Lyc-O-Mato® in soft gel capsules was associated with a significant drop in both systolic and diastolic blood pressure after eight weeks of supplementation of a normal diet.
- Study Indicates That Lyc-O-Mato® Reduces Blood Pressure
Randomized double blind, placebo controlled crossover trial, conducted at Ben-Gurion University, Israel, indicated that a daily intake of tomato extract Lyc-O-Mato® in soft gel capsules was associated with a significant drop in both systolic and diastolic blood pressure after eight weeks of supplementation of a normal diet.
- Study Indicates That Lyc-O-Mato® Reduces Blood Pressure
Randomized double blind, placebo controlled crossover trial, conducted at Ben-Gurion University, Israel, indicated that a daily intake of tomato extract Lyc-O-Mato® in soft gel capsules was associated with a significant drop in both systolic and diastolic blood pressure after eight weeks of supplementation of a normal diet.
- Study Indicates That Lyc-O-Mato® Reduces Blood Pressure
Randomized double blind, placebo controlled crossover trial, conducted at Ben-Gurion University, Israel, indicated that a daily intake of tomato extract Lyc-O-Mato® in soft gel capsules was associated with a significant drop in both systolic and diastolic blood pressure after eight weeks of supplementation of a normal diet.
- Study Indicates That Lyc-O-Mato® Reduces Blood Pressure
Randomized double blind, placebo controlled crossover trial, conducted at Ben-Gurion University, Israel, indicated that a daily intake of tomato extract Lyc-O-Mato® in soft gel capsules was associated with a significant drop in both systolic and diastolic blood pressure after eight weeks of supplementation of a normal diet.
- Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award
The 2009 Frost & Sullivan European Functional Food & Beverage Microencapsulation Technology Innovation Award has been presented to GAT Food Essentials GmbH in recognition of its proprietary wowCAPS(R) technology.
- Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award
The 2009 Frost & Sullivan European Functional Food & Beverage Microencapsulation Technology Innovation Award has been presented to GAT Food Essentials GmbH in recognition of its proprietary wowCAPS(R) technology.
- Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award
The 2009 Frost & Sullivan European Functional Food & Beverage Microencapsulation Technology Innovation Award has been presented to GAT Food Essentials GmbH in recognition of its proprietary wowCAPS(R) technology.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- Synergy Flavors Invests in Sensory Flavor Profiling Research
Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients.
- Synergy Flavors Invests in Sensory Flavor Profiling Research
Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients.
- Synergy Flavors Invests in Sensory Flavor Profiling Research
Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients.
- Synergy Flavors Invests in Sensory Flavor Profiling Research
Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients.
- Synergy Flavors Invests in Sensory Flavor Profiling Research
Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- NPI Daily - Top of The News for Nov. 20, 2009 - FDA Issues 22 Warning Letters to Website Operators
Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award; Synergy Flavors Invests in Sensory Flavor Profiling Research; FDA Issues 22 Warning Letters to Website Operators; Nordic Naturals Ultimate Omega™ First Fish Oil to Participate in NFL/NFLPA Sports Nutrition Label Certification Program; BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates; New Organic Berry Whole Food Energy Bar from Amazing Grass Delivers Whole Food Nutrition; Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
- NPI Daily - Top of The News for Nov. 20, 2009 - FDA Issues 22 Warning Letters to Website Operators
Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award; Synergy Flavors Invests in Sensory Flavor Profiling Research; FDA Issues 22 Warning Letters to Website Operators; Nordic Naturals Ultimate Omega™ First Fish Oil to Participate in NFL/NFLPA Sports Nutrition Label Certification Program; BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates; New Organic Berry Whole Food Energy Bar from Amazing Grass Delivers Whole Food Nutrition; Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
- Heart Health Alert: Niacin May Reverse Hardening of the Arteries
- Heart Health Alert: Niacin May Reverse Hardening of the Arteries
- Heart Health Alert: Niacin May Reverse Hardening of the Arteries
- Heart Health Alert: Niacin May Reverse Hardening of the Arteries
- Spotlight on Savory Side Dishes
- Spotlight on Savory Side Dishes
- Spotlight on Savory Side Dishes
- Another Reason to Choose Healthy Lifestyle Habits
- Another Reason to Choose Healthy Lifestyle Habits
|
SANTA CLARA, Calif., Dec. 20, 2005 (PRIMEZONE) -- A randomized, double-blind, placebo-controlled, multi-center study authored by Matthias Rath, M.D. and his colleagues proves that regular supplementation with micronutrients can safely and effectively reduce the frequency and severity of arrhythmic episodes. Results of the study were published in the November 2005 issue of JANA, Journal of the American Nutraceutical Association.
Arrhythmic episodes affect 30-60 percent of people between the ages of 50-70. These episodes involve irregular heartbeat, a frightening experience causing dizziness and shortness of breath and carrying a risk of a sudden cardiac event. In most cases, conventional medicine cannot explain why arrhythmia develops and drugs used to address this problem carry severe side effects.
This study, conducted in Germany, involved 131 patients aged 18-70, who had been diagnosed with paroxysmal atrial arrhythmia. Participants were advised to continue prescribed medication and were treated with either an essential nutrient formulation or a placebo during the 24-week study.
Analysis of data demonstrated a statistically significant decrease in the frequency of clinically apparent arrhythmic episodes with vitamin/essential nutrient supplementation that improved with time: 45.5% of the group experienced frequent arrhythmic episodes after three months of taking supplements, while only 27.3% of the group experienced them after six months of taking supplements. In addition, the vitamin-supplemented group had a statistically significant decrease in depression compared with patients following the drug regimen only.
The study was based on the biochemical fact that a deficiency of essential micronutrients impairs cellular bio-energy production and can lead to disturbances in the generation and conduction of electrical impulses in the wall of the heart. "By addressing the underlying cause of arrhythmia, a deficiency in nutrients that generate bio-energy in the heart muscle cells, the nutritional program provides a safe and effective reduction of arrhythmic episodes," the study states.
The study results were corroborated by another recently published study in the August 2005 European Heart Journal, "The effect of micronutrient supplementation on quality-of-life and left ventricular function in elderly patients with chronic heart failure" by Klaus K.A. Witte, et al. This study's findings showed significant health benefits of micronutrient intake in patients suffering from heart failure.
Because conventional medicine doesn't recognize the deficiency of bio-energy in the heart muscle as the primary cause of arrhythmia, it can only offer symptomatic treatments such as pacemakers, cauterization procedures and anti-arrhythmic pharmaceutical drugs that merely mask symptoms. All these treatments come with severe side effects. Anti-arrhythmic drugs frequently worsen the irregular heartbeat, cause cardiac arrest and sometimes cause the premature deaths of patients.
The JANA study was entitled "Reduction in the Frequency of Arrhythmic Episodes in Patients with Paroxysmal Atrial Arrhythmia with a Vitamin/Essential Nutrient Supplementation Program," and was authored by Matthias Rath, M.D., Tatiana Kalinovsky, MSRN, and Aleksandra Niedzwiecki, Ph.D.
JANA is edited by Mark Houston, the clinical professor of medicine at Vanderbilt University Medical School and Medical Director at Hypertension and Vascular Biology Institute and the Life Extension Institute at Saint Thomas Hospital and Medical Center in Nashville, Tennessee. The Dr. Rath Research Institute offers innovative, safe and effective natural solutions to heart disease. To learn more, visit www.drrathresearch.org. |